Article
<u>ST</u>udy of <u>A</u>lteplase for <u>R</u>espiratory Failure in <u>S</u>ARS-CoV-2 COVID-19 (STARS): A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized, Controlled Trial
2021-06-10
Abstract excerpt
Background: Pulmonary vascular microthrombi have been proposed as a mechanism of COVID19 respiratory failure. We hypothesized that early administration of tissue-plasminogen activator(tPA) followed by therapeutic heparin would improve pulmonary function in these patients.<br><br>Methods: Adults with COVID-19-induced respiratory failure were randomized May14, 2020-March 3, 2021 in two phases: Phase-1(n=36): control...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f753af6-5171-5921-bbde-e9b7b41ce654
- DOI
- 10.2139/ssrn.3859327
